PCM
EBS icon

Prelude Capital Management’s Emergent Biosolutions EBS Stock Holding History

Prelude Capital Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-185
Closed -$9K – 1780
2019
Q1 		$9K Sell
185
-28
-13% -$1.65K ﹤0.01% 1460
2018
Q4 		$13K Buy
213
+73
+52% +$4.71K ﹤0.01% 1316
2018
Q3 		$9K Buy
+140
New +$8.17K ﹤0.01% 1473
2017
Q4 		– Sell
-1,700
Closed -$69K – 1434
2017
Q3 		$69K Buy
1,700
+100
+6% +$3.62K 0.01% 1006
2017
Q2 		$54K Sell
1,600
-7,583
-83% -$234K 0.01% 978
2017
Q1 		$267K Sell
9,183
-2,298
-20% -$70K 0.03% 463
2016
Q4 		$377K Buy
11,481
+4,088
+55% +$123K 0.05% 377
2016
Q3 		$233K Buy
7,393
+2,817
+62% +$81.9K 0.02% 519
2016
Q2 		$129K Sell
4,576
-698
-13% -$27.4K 0.02% 657
2016
Q1 		$192K Buy
+5,274
New +$186K 0.03% 571
2015
Q3 		– Sell
-2,224
Closed -$73K – 1549
2015
Q2 		$73K Buy
+2,224
New +$68.9K 0.01% 1007
2015
Q1 		– Sell
-1,500
Closed -$41K – 1990
2014
Q4 		$41K Sell
1,500
-5,100
-77% -$122K 0.01% 1339
2014
Q3 		$141K Buy
6,600
+500
+8% +$11.4K 0.02% 886
2014
Q2 		$137K Buy
6,100
+5,600
+1,120% +$130K 0.02% 917
2014
Q1 		$13K Buy
+500
New +$12.6K ﹤0.01% 1746
2013
Q4 		– Sell
-340
Closed -$6K – 1690
2013
Q3 		$6K Buy
+340
New +$6.07K ﹤0.01% 1410

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Prelude Capital Management's EBS Position: Q2 2019 in Review

Prelude Capital Management sold out of Emergent Biosolutions (EBS) in Q2 2019, closing a stake of 185 shares — an estimated $9K sold.

Prelude Capital Management first reported a position in EBS in Q3 2013 and held it in 16 quarters. The position peaked at $377K in Q4 2016. 233 funds tracked by Wall St. Rank hold EBS as of Q2 2019.

  • Prelude Capital Management reported no remaining Emergent Biosolutions position as of Q2 2019 after selling out during the quarter.
  • Prelude Capital Management sold 185 Emergent Biosolutions shares in Q2 2019, an estimated $9K.
  • Prelude Capital Management first reported a position in Emergent Biosolutions in Q3 2013 and held it in 16 quarters.
  • Prelude Capital Management's Emergent Biosolutions position peaked at $377K in Q4 2016.
  • 233 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2019.

Based on Prelude Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.